C0006674||Vitamin D3
C0078939||Aβ peptide
C0596402||cytotoxicity
C0086418||human
C0027819||neuroblastoma
C0007634||SH- SY5Y cells
C3537343||S1P1
C1120843||p38MAPK
C0101379||ATF4
C0262950||bone
C1159402||metabolism regulation
C0006674||1alpha, 25-dihydroxyvitamin D3
C0006674||1,25(OH)2D3
C0040300||tissues
C0027763||nervous system
C0019932||hormone
C0242912||neuroprotective
C0003392||antiproliferating
C1511939||differentiating agent
C0037900||Sphingolipids
C0574031||bioactive lipids
C1327622||regulating cell fate
C0037900||sphingolipids
C0006674||1,25(OH)2D3
C0006674||1,25(OH)2D3
C0078939||amyloid-β peptide
C0078939||Aβ(1-42)
C0596402||cytotoxicity
C1515655||in vivo
C0007634||differentiated SH-SY5Y cells
C0078939||Aβ(1-42)
C0074992||sphingosine-1-phosphate
C0074992||sphingosine-1-phosphate
C0007745||ceramide
C0007745||ceramide
C0006674||1,25(OH)2D3
C0006674||1,25(OH)2D3
C0078939||Aβ(1-42)
C1150463||sphingosine kinase activity
C0006674||1,25(OH)2D3
C2984468||S1P signaling pathways
C1514758||activation
C0390526||S1P receptor subtype S1P1
C0006674||1,25(OH)2D3
C0390526||S1P1
C0078939||Aβ(1-42)
C3537152||downstream signaling
C3178870||ER stress damage
C1120843||p38MAPK
C0101379||ATF4
C1173774||ZK191784
C0087111||chronic treatment
C0006674||1,25(OH)2D3
C0078939||Aβ(1-42)
C0010957||damage
C0694598||CA1 region
C0086893||rat
C0019564||hippocampus
C0596290||cell proliferation
C0152314||hippocampal dentate gyrus
C0025929||mice
C0006674||1,25(OH)2D3
C0243071||structural analogue
C1173774||ZK191784
C0078939||Aβ(1-42) peptide
C0600688||toxicity
C0037080||S1P/S1P1/p38MAPK/ATF4 pathway
C0007634||SH-SY5Y cells